GeneDx Corp. (WGS)
NASDAQ: WGS
· Real-Time Price · USD
64.58
-1.79 (-2.70%)
At close: Jun 13, 2025, 3:59 PM
64.30
-0.43%
After-hours: Jun 13, 2025, 05:59 PM EDT
GeneDx Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2022 |
|---|---|---|
| Diagnostic Test Revenue | 302.16M | 227.33M |
| Diagnostic Test Revenue Growth | +32.91% | n/a |
| Diagnostic Test, Institutional Customers Revenue | 65.11M | 46.12M |
| Diagnostic Test, Institutional Customers Revenue Growth | +41.17% | n/a |
| Diagnostic Test, Self Pay Revenue | 2.34M | 7.59M |
| Diagnostic Test, Self Pay Revenue Growth | -69.11% | n/a |
| Diagnostic Test, Third Party Insurance Revenue | 234.7M | 173.62M |
| Diagnostic Test, Third Party Insurance Revenue Growth | +35.18% | n/a |
| Product and Service, Other Revenue | 3.29M | 7.36M |
| Product and Service, Other Revenue Growth | -55.26% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2024 |
|---|---|
| Other Revenue | 3.16M |
| Other Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 50.45M | 45.03M | 43.17M | 37.31M | 33.45M | 37.24M | 42.86M | 52.52M | 57.14M | 72.44M | 89.31M | 104.15M | 72.33M | 88.6M | 55.35M | 29.04M | 137.4M | 91.14M | 37.08M |
| Selling, General, and Administrative Revenue Growth | +12.05% | +4.30% | +15.71% | +11.53% | -10.18% | -13.11% | -18.39% | -8.08% | -21.12% | -18.89% | -14.25% | +43.99% | -18.36% | +60.07% | +90.60% | -78.86% | +50.75% | +145.82% | n/a |
| Research and Development Revenue | 12.58M | 11.59M | 11.66M | 10.69M | 11.37M | 10.03M | 14.29M | 17.14M | 14.59M | 24.37M | 13.35M | 27.17M | 21.32M | 22.25M | 17.83M | 11.95M | 53.13M | 31.16M | 19.08M |
| Research and Development Revenue Growth | +8.53% | -0.66% | +9.11% | -5.98% | +13.38% | -29.81% | -16.63% | +17.45% | -40.11% | +82.46% | -50.85% | +27.46% | -4.19% | +24.76% | +49.16% | -77.50% | +70.52% | +63.29% | n/a |
| Sales and Marketing Revenue | 18.32M | 17.68M | 17.02M | 16.59M | 16.09M | 15.56M | 16.76M | 15.32M | 13.45M | 31.8M | 37.45M | 36.12M | 29.55M | 30.65M | 22.12M | 16.25M | 35.37M | 30.03M | 12.73M |
| Sales and Marketing Revenue Growth | +3.62% | +3.82% | +2.65% | +3.11% | +3.38% | -7.18% | +9.38% | +13.92% | -57.69% | -15.10% | +3.69% | +22.24% | -3.59% | +38.54% | +36.15% | -54.06% | +17.77% | +135.80% | n/a |